BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20010869)

  • 1. Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer.
    Komiya T; Coxon A; Park Y; Chen WD; Zajac-Kaye M; Meltzer P; Karpova T; Kaye FJ
    Oncogene; 2010 Mar; 29(11):1672-80. PubMed ID: 20010869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation.
    Zhou X; Li JW; Chen Z; Ni W; Li X; Yang R; Shen H; Liu J; DeMayo FJ; Lu J; Kaye FJ; Wu L
    Elife; 2021 Jun; 10():. PubMed ID: 34142658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancer.
    Cao C; Gao R; Zhang M; Amelio AL; Fallahi M; Chen Z; Gu Y; Hu C; Welsh EA; Engel BE; Haura EB; Cress WD; Wu L; Zajac-Kaye M; Kaye FJ
    J Natl Cancer Inst; 2015 Jan; 107(1):358. PubMed ID: 25465874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
    Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
    Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.
    Amelio AL; Fallahi M; Schaub FX; Zhang M; Lawani MB; Alperstein AS; Southern MR; Young BM; Wu L; Zajac-Kaye M; Kaye FJ; Cleveland JL; Conkright MD
    Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3260-8. PubMed ID: 25071166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adrenergic-regulated CRTC1 and CRTC2 phosphorylation and cellular distribution is independent of endogenous SIK1 in the male rat pinealocyte.
    McTague J; Ferguson M; Chik CL; Ho AK
    Mol Cell Endocrinol; 2015 Oct; 414():156-67. PubMed ID: 26210066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.
    Chen J; Li JL; Chen Z; Griffin JD; Wu L
    BMC Cancer; 2015 Oct; 15():803. PubMed ID: 26503699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CREB coactivator CRTC2 promotes oncogenesis in LKB1-mutant non-small cell lung cancer.
    Rodón L; Svensson RU; Wiater E; Chun MGH; Tsai WW; Eichner LJ; Shaw RJ; Montminy M
    Sci Adv; 2019 Jul; 5(7):eaaw6455. PubMed ID: 31355336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss.
    Feng Y; Wang Y; Wang Z; Fang Z; Li F; Gao Y; Liu H; Xiao T; Li F; Zhou Y; Zhai Q; Liu X; Sun Y; Bardeesy N; Wong KK; Chen H; Xiong ZQ; Ji H
    Cancer Res; 2012 Dec; 72(24):6502-11. PubMed ID: 23074285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion.
    Gu Y; Lin S; Li JL; Nakagawa H; Chen Z; Jin B; Tian L; Ucar DA; Shen H; Lu J; Hochwald SN; Kaye FJ; Wu L
    Oncogene; 2012 Jan; 31(4):469-79. PubMed ID: 21706049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth.
    Schumacher Y; Aparicio T; Ourabah S; Baraille F; Martin A; Wind P; Dentin R; Postic C; Guilmeau S
    Oncogene; 2016 May; 35(20):2602-14. PubMed ID: 26300003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth.
    Chen Z; Li JL; Lin S; Cao C; Gimbrone NT; Yang R; Fu DA; Carper MB; Haura EB; Schabath MB; Lu J; Amelio AL; Cress WD; Kaye FJ; Wu L
    J Clin Invest; 2016 Jun; 126(6):2267-79. PubMed ID: 27140397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
    Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
    Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids Alter CRTC-CREB Signaling in Muscle Cells: Impact on PGC-1α Expression and Atrophy Markers.
    Rahnert JA; Zheng B; Hudson MB; Woodworth-Hobbs ME; Price SR
    PLoS One; 2016; 11(7):e0159181. PubMed ID: 27404111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
    Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
    Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade.
    Katoh Y; Takemori H; Lin XZ; Tamura M; Muraoka M; Satoh T; Tsuchiya Y; Min L; Doi J; Miyauchi A; Witters LA; Nakamura H; Okamoto M
    FEBS J; 2006 Jun; 273(12):2730-48. PubMed ID: 16817901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
    O'Neill ID
    Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.
    Lennerz JK; Perry A; Mills JC; Huettner PC; Pfeifer JD
    Am J Surg Pathol; 2009 Jun; 33(6):835-43. PubMed ID: 19092631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.
    Coxon A; Rozenblum E; Park YS; Joshi N; Tsurutani J; Dennis PA; Kirsch IR; Kaye FJ
    Cancer Res; 2005 Aug; 65(16):7137-44. PubMed ID: 16103063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC.
    Hollstein PE; Eichner LJ; Brun SN; Kamireddy A; Svensson RU; Vera LI; Ross DS; Rymoff TJ; Hutchins A; Galvez HM; Williams AE; Shokhirev MN; Screaton RA; Berdeaux R; Shaw RJ
    Cancer Discov; 2019 Nov; 9(11):1606-1627. PubMed ID: 31350328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.